Johns Hopkins Medicine account plan
medical research teaching patient care
At a glance
Johns Hopkins Medicine's health system runs six hospitals, health plans and pharmacies, with $9,639.1 million of FY2025 operating revenues.
The Johns Hopkins Health System Corporation (JHHS) is the Maryland not-for-profit parent of the Johns Hopkins Medicine clinical enterprise: The Johns Hopkins Hospital in East Baltimore, the Bayview, Howard County, Suburban and Sibley Memorial community hospitals, Johns Hopkins All Children's Hospital in Florida, a physician group, home care, pharmacies and the Johns Hopkins Health Plans. It serves patients primarily in Maryland, the District of Columbia and Florida, while the Johns Hopkins University, a separate legal entity, supplies the physicians and research. In FY2025 (year ended June 30, 2025) total operating revenues and other support were $9,639.1 million (FY2024: $9,047.9 million), income from operations $192.8 million and excess of revenues over expenses $542.5 million. JHHS also centralises shared services such as finance, HR, payroll, purchasing and patient financial services for its affiliates.
Business units
Hospitals and patient care
Net patient service revenue $5,717.3 million in FY2025, about 59% of operating revenuesSix hospitals: The Johns Hopkins Hospital (academic medical center), Johns Hopkins Bayview, Howard County and Suburban in Maryland, Sibley Memorial in Washington, D.C., and Johns Hopkins All Children's in Florida. The four Maryland hospitals run under HSCRC global budget revenue agreements; Medicare is the largest payer at 27.3% of patient revenue. Net patient service revenue rose from $5,290.2 million in FY2024.
Johns Hopkins Health Plans
Insurance premium revenue $2,522.3 million in FY2025, about 26% of operating revenuesA managed-care company owned 50% by JHHS and 50% by the University: Priority Partners (Maryland Medicaid MCO, $1.800 billion of premiums), the Uniformed Services Family Health Plan for TRICARE beneficiaries ($497.6 million, contract to September 30, 2033) and Hopkins Health Advantage (Medicare Advantage, $226.1 million). Premium revenue was flat year on year.
Pharmacy, home care and services
Other revenue $1,377.4 million in FY2025, about 14% of operating revenuesOutpatient pharmacies with standard, specialty and over-the-counter medications ($786.5 million, up from $655.7 million), Potomac home health and home support, a stake in Johns Hopkins Home Care Group, staffing and supply-chain units, and imaging management for the University.
Physician, ambulatory and network businesses
Johns Hopkins Community Physicians, the Johns Hopkins Clinical Alliance network supporting independent physicians in value-based care, and 50% stakes in ambulatory surgery centers.
International and equity affiliates
Equity-method stakes including Johns Hopkins Medicine International (50%), Mt. Washington Pediatric Hospital (50%) and JHMI Utilities (50%).
Strategic priorities
- Academic medicine with the University
- JHHS paid the University $527.7 million for medical services in FY2025 and approved a $62.5 million contribution to the School of Medicine's research and education mission in June 2025.
- East Baltimore campus build-out
- A medical research building on The Johns Hopkins Hospital campus is opening in phases between 2024 and 2026; JHHS committed up to $70.0 million to School of Medicine research operations in it through fiscal 2029.
- Population-based payment in Maryland
- Maryland's model fixes each hospital's revenue base annually regardless of volume and patient mix for Maryland residents, under a waiver approved through calendar year 2027.
- Growing pharmacy and outpatient revenue
- Outpatient pharmacy revenues rose to $786.5 million from $655.7 million and other revenue to $1,377.4 million from $1,214.8 million.
- Physician recruitment
- JHHS pledged $66.0 million in 2021 for recruiting clinically focused physicians, and the hospital endowment funds start-up packages for department directors and chairs.
Investments and deals
- Capital spending
- Purchases of property, plant and equipment were $293.1 million in FY2025 (FY2024: $307.9 million), with construction in progress of $202.1 million.
- Medical research building
- JHH's share of the research building under construction was $92.5 million at June 30, 2025; the University funds 65% of construction costs.
- Bond refinancing
- In August 2024 JHHS refinanced its Series 2016B, 2018A and 2018B bonds into 2024 Series A, B and C variable rate demand bonds; parity debt was $1.6 billion.
Challenges and risks
- Thin operating margin
- Operating expenses of $9,446.4 million left income from operations of $192.8 million in FY2025; purchased services ($3,575.9 million) and salaries, wages and benefits ($3,484.6 million) are the biggest costs.
- Litigation
- The Kowalski verdict against All Children's Hospital stands at $214.0 million, including $50.0 million of punitive damages not covered by insurance, under appeal; USFHP payment litigation with the U.S. Government is ongoing.
- Government payer concentration
- Priority Partners depends on an annually renewed Maryland HealthChoice contract and Hopkins Health Advantage on an annual CMS contract; Medicare (27.3%) and Medicaid/Medicaid MCO (16.4%) are large shares of patient revenue.
- Federal policy change
- The One Big Beautiful Bill Act, enacted July 4, 2025, includes tax and regulatory changes whose impact JHHS will evaluate in fiscal 2026.
Where a supplier can help
- Purchased services and outsourcing
- Tied to the thin operating margin: purchased services are the single largest cost line, so suppliers that cut outsourced service or supply costs speak directly to the system's economics.
- Revenue cycle and payer compliance
- Tied to government payer concentration and the compliance risks: revenue-cycle, audit-readiness and coding tools help a system paid largely by Medicare, Medicaid and TRICARE.
- Pharmacy operations
- Tied to growing pharmacy revenue: specialty pharmacy, inventory and dispensing technology fit a business that grew to $786.5 million.
- Research and campus facilities
- Tied to the medical research building and campus capital spending: equipment, construction and facilities-management suppliers have a live programme through 2026.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Johns Hopkins Medicine?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- The Johns Hopkins Health System Corporation and Affiliates: Consolidated Financial Statements FY2025 (year ended June 30, 2025) and Uniform Guidance reports
- Johns Hopkins Health System Corporation (JHHS) is the not-for-profit parent of the Johns Hopkins Medicine clinical enterprise: The Johns Hopkins Hospital (academic medical center), Johns Hopkins Bayview, Howard County, Suburban and Sibley Memorial community hospitals, Johns Hopkins All Children's Hospital in Florida, a physician group, home care, and the Johns Hopkins Health Plans managed-care business; the Johns Hopkins University is a separate legal entity that supplies the physicians and research.
- FY2025 (year ended June 30, 2025): total operating revenues and other support of $9,639.1 million (FY2024: $9,047.9 million); income from operations $192.8 million (FY2024: $134.6 million); excess of revenues over expenses $542.5 million, helped by $514.9 million of net investment return.
- Revenue mix: net patient service revenue $5,717.3 million, insurance premium revenue $2,522.3 million (health plans), other revenue $1,377.4 million, of which outpatient pharmacy revenues $786.5 million.
- Payer mix of patient revenue: Medicare 27.3%, HMO 21.2%, Blue Cross 19.3%, Medicaid/Medicaid MCO 16.4%, Commercial 8.2%, self pay 2.1%. Four Maryland hospitals run under HSCRC global budget revenue agreements, under the Maryland waiver approved through calendar year 2027.
- Health plans: Priority Partners (Maryland Medicaid MCO, 50% joint venture) $1.800 billion of premiums; USFHP TRICARE contract with the Department of Defense $497.6 million (sole-source contract to September 30, 2033); Hopkins Health Advantage (Medicare Advantage) $226.1 million.
- Balance sheet at June 30, 2025: total assets $11,184.5 million, cash and cash equivalents $1,057.4 million, investments $4,193.1 million, long-term debt $1,421.0 million net of current portion; total net assets $7,107.1 million. Capex: $293.1 million of property, plant and equipment purchases.
- Biggest cost lines: purchased services $3,575.9 million and salaries, wages and benefits $3,484.6 million; JHHS paid the University $527.7 million for medical services under its agreements and approved a $62.5 million contribution to the School of Medicine's research and education mission.
- Risks named: a $214.0 million verdict (Kowalski v. Johns Hopkins All Children's Hospital, $50.0 million punitive) under appeal; USFHP payment litigation with the U.S. Government; government program compliance; the One Big Beautiful Bill Act enacted July 4, 2025, whose impact JHHS will evaluate in FY2026.
Questions about Johns Hopkins Medicine
What is Johns Hopkins Medicine's health system?
The Johns Hopkins Health System Corporation is the not-for-profit parent of the clinical side of Johns Hopkins Medicine: six hospitals in Maryland, Washington, D.C. and Florida, physician groups, home care, pharmacies and the Johns Hopkins Health Plans.
What was the Johns Hopkins Health System's revenue in FY2025?
Total operating revenues and other support were $9,639.1 million in the year ended June 30, 2025, up from $9,047.9 million, with income from operations of $192.8 million.
How is the health system related to the Johns Hopkins University?
They are separate legal entities. The University's School of Medicine faculty provide clinical services and run research in JHHS hospitals, and JHHS paid the University $527.7 million for medical services in FY2025.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)